Navigation Links
Anti-dsDNA, surface-expressed TLR4 and endosomal TLR9 cooperate to exacerbate lupus
Date:6/12/2014

Systemic lupus erythematosus (SLE) is a complicated multifactorial autoimmune disease influenced by many genetic and environmental factors. The hallmark of systemic lupus erythematosus (SLE) is the presence of high levels of anti-double-stranded DNA autoantibody (anti-dsDNA) in sera. In addition, greater infection rates are found in SLE patients and higher morbidity and mortality usually come from bacterial infections. Deciphering interactions between the susceptibility genes and the environmental factors for lupus complex traits is challenging and has resulted in only limited success.

In the June issue of Experimental Biology and Medicine Lee et al, from National Yang-Ming University in Taiwan, studied the role of anti-double stranded DNA (anti-dsDNA) and the Toll-like receptors (TLRs), TLR4 and TLR9, in the pathogenesis of lupus. They prepared transgenic mice carrying the anti-dsDNA transgene and challenged these mice with TLR4 and TLR9 agonists. They demonstrate that in the anti-dsDNA transgenic mice TLR4 and TLR9 are cooperatively linked to Lupus progression.

''Since simultaneous activation of extracellular and intracellular pattern-recognition receptors (PRR) is able to trigger more intense host immune responses, it is really crucial to determine whether co-engagement of extracellular and intracellular PRRs may increase disease severity in lupus,'' said Dr. Kuang-Hui Sun, corresponding author. However, only individual conditional knockout models were used in previous studies to study the roles of TLR4 or TLR9. In addition, intracellular nucleic acid-sensing TLR9 plays either stimulatory or protective roles in different murine lupus models. Therefore, Sun and colleagues injected the ligands of TLR4 and TLR9 into the anti-dsDNA transgenic mice as a new model to investigate whether anti-dsDNA and co-activation of extracellular TLR4 and endosomal TLR9 impacts the pathogenesis of lupus in normal background mice. Their data suggest that, in addition to anti-dsDNA, signaling pathways triggered by simultaneous activation of surface-expressed TLR4 and endosomal TLR9 can promote the progression of SLE. These results suggest that simultaneous targeting of anti-dsDNA, TLR4 and 9 may be a potential therapy for SLE.

Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine, said "These studies in transgenic mice offer new concepts for affecting immune tolerance and reducing SLE disease progression as future therapeutics are developed."


'/>"/>

Contact: Kuang-Hui Sun
khsun@ym.edu.tw
Society for Experimental Biology and Medicine
Source:Eurekalert

Related medicine news :

1. How men and women cooperate
2. Health-care practitioners must cooperate to reduce medication mismanagement, MU expert says
3. EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022
4. Putting Lupus in permanent remission
5. There Will be a Michigan Lupus Foundation Support Group Meeting in Traverse City on Wednesday, November 20th
6. Headaches in lupus patients not linked to disease activity study says
7. Young, black women at highest risk for lupus, suffer more life-threatening complications
8. The Michigan Lupus Foundation Will Be Holding a Lupus Support Group Meeting in Lapeer, MI on October 8th
9. The Michigan Lupus Foundation Will Be Holding a Lupus Support Group Meeting in Livonia on August 21st
10. The Michigan Lupus Foundation Will Be Holding a Lupus Support Group Meeting in Lapeer on Tuesday, August 13th
11. The Michigan Lupus Foundation Will Be Holding a Lupus Support Group in Southfield on Saturday, August 10th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2017)... ... 2017 , ... ProBrand Glitch is a set of 30 glitch distortion logo reveals made exclusively ... any logo with a glitch reveal in just a few clicks of a mouse. Customizable ... of each preset. Use these presets to add a uniquely animated logo to any photos ...
(Date:2/18/2017)... VA (PRWEB) , ... February ... ... of Change for Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, March ... , Are manufacturers looking to reduce their regulatory burden? Pay dividends in ...
(Date:2/18/2017)... ... 17, 2017 , ... CONTACT:, Glenn Vallecillos, MD, FACS, +1 ... Dr. Glenn Vallecillos experiments SculpSure, the hot, new, aesthetic, non-surgical procedure ... been centered around that idea that to achieve ones desired results a surgical ...
(Date:2/18/2017)... , ... February 18, 2017 , ... ... provides the latest information and contact points to easily connect elderly veterans of ... assisted living, and elder-care funding. It also conveys material on this year's increase ...
(Date:2/17/2017)... San Diego, CA (PRWEB) , ... February 17, ... ... new initiative—InvestUp—to focus on foundational and sustainable systems change designed to further positively ... Counties. , “The Board of Trustees has long considered it our duty to ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... , Feb. 20, 2017 Provides understanding ... and agreements entered into by the worlds leading ... https://www.reportbuyer.com/product/3605699/ Description The Global Renal Failure ... understanding and access to partnering deals and agreements ... - Trends in partnering deals ...
(Date:2/20/2017)... Systems Magnetic resonance imaging (MRI) ... the organs and tissues in the body with the ... technique does not use ionizing radiation either for the ... of cancer. MRI is used for a variety of ... orthopedics. Hence, MRI helps in the diagnosis and treatment ...
(Date:2/20/2017)... report analyzes the worldwide markets for Drug-Eluting Stents in US$ Million. ... Canada , Japan , Europe ... , and Rest of World. Read the ... ... 2015 through 2022. Also, a six-year historic analysis is provided for ...
Breaking Medicine Technology: